Stock Rich List
#642 on the corporate holders of 809 holders

Flagship Pioneering Fund VI, L.P.

10% owner at Generate Biomedicines.

$94.6M
in disclosed stock, −$91K (−0.10%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
642nd of 809
Companies held
1
Largest holding
GENB, 100.0% of total
Latest SEC filing
Mar 2, 2026
Listed but not counted
$374M

What the $94.6M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Generate Biomedicines GENB
Common Stock
Through Flagship VentureLabs VI, LLC
Reported jointly by 3 insiders; split evenly
8,338,819$10.37$86.5M91.4%Form 4, Feb 26, 2026
Generate Biomedicines GENB
Common Stock
Through Pioneering Medicines 02, LLC
Reported jointly by 2 insiders; split evenly
781,250$10.37$8.1M8.6%Form 4, Mar 2, 2026

Share counts are the amounts Flagship Pioneering Fund VI, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Flagship Pioneering Fund VI, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Generate Biomedicines GENB
Common Stock
Through Flagship Pioneering Fund VII, L.P.
Held by a company or fund the insider manages
15,264,724$10.37$158M—Form 4, Mar 2, 2026
Generate Biomedicines GENB
Common Stock
Through Flagship Pioneering Fund VI, L.P.
Held by an investment fund or partnership
12,723,940$10.37$132M—Form 4, Mar 2, 2026
Generate Biomedicines GENB
Common Stock
Through FPN II, L.P.
Held by a company or fund the insider manages
4,340,252$10.37$45.0M—Form 4, Mar 2, 2026
Generate Biomedicines GENB
Common Stock
Through Flagship Pioneering Special Opportunities Fund II, L.P.
Held by a company or fund the insider manages
2,777,752$10.37$28.8M—Form 4, Mar 2, 2026
Generate Biomedicines GENB
Common Stock
Through Nutritional Health LTP Fund, L.P.
Held by a company or fund the insider manages
987,491$10.37$10.2M—Form 4, Mar 2, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Mar 2, 2026BoughtGENB1,562,500$16.00$25.0MView
Mar 2, 2026BoughtGENB1,562,500$16.00$25.0MView
Mar 2, 2026BoughtGENB1,562,500$16.00$25.0MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
639Diana Shipping Inc.
10% owner, Genco Shipping & Trading
$96.2M−$2.0M (−2.02%)
640Fhmls Xi, L.P.
10% owner, Attovia Therapeutics
$95.9M+$308K (+0.32%)
641Nutritional Health LTP Fund General Partner LLC
10% owner, Generate Biomedicines
$94.6M−$91K (−0.10%)
642Flagship Pioneering Fund VI, L.P.
10% owner, Generate Biomedicines
$94.6M−$91K (−0.10%)
643DME Advisors GP, L.L.C.
Director, Green Brick Partners
$94.2M−$2.7M (−2.83%)
644DME Advisors, LP
Director, Green Brick Partners
$94.2M−$2.7M (−2.83%)
645Brookfield Oaktree Holdings, LLC
10% owner, Expand Energy
$94.2M−$1.9M (−1.94%)

Other Generate Biomedicines insiders

All GENB insiders

Questions

How much stock does Flagship Pioneering Fund VI, L.P. own?

Flagship Pioneering Fund VI, L.P. holds $94,575,119 in listed stock based on SEC filings and current prices, mostly Generate Biomedicines (GENB). That ranks 642nd on the Stock Rich List.

Is this Flagship Pioneering Fund VI, L.P.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Flagship Pioneering Fund VI, L.P. last buy or sell stock?

The most recent open-market trade on file is a purchase of 1,562,500 GENB shares on Mar 2, 2026 at $16.00.

Files jointly with Noubar B. Afeyan.